Clinical trials
Lytix reaches milestone in melanoma study
The Norwegian biotech company and Oslo Cancer Cluster member has met the primary endpoint in a Phase II melanoma study.
News and press releases
School collaborationUllern-elever hos Thermo Fisher Scientific
16 elever fra Medisinsk Innovasjon ved Ullern videregående skole fikk et sjeldent innblikk i produksjonen av Dynabeads hos Thermo Fisher Scientific på Lillestrøm.
Cell therapyNordic collaboration can advance cell therapy
The Cell Therapy Innovation Ecosystem Meeting at Oslo Cancer Cluster brought together perspectives from Sweden, Norway, Denmark and Germany on how collaboration can bring advanced therapies closer to cancer patients.
Start-upIncubator invests in two oncology start-ups
Oslo Cancer Cluster Incubator has become a shareholder in Oncosyne and Immunoquest, two start-ups developing new approaches to more precise cancer treatments.
School collaborationUllern-elever imponerte og engasjerte i «Ta ordet»-konkurransen
Engasjement, sterke budskap og imponerende formidlingsevne preget skolefinalen i «Ta ordet» konkurransen ved Ullern videregående skole. Ni klassevinnere konkurrerte om å holde den beste argumenterende talen om alt fra kroppspress og likestilling til ytringsfrihet, trygghet og arbeidsvilkår.
MembersNordicRWE awarded NOK 16 million
NordicRWE, a member of Oslo Cancer Cluster, has received NOK 16 million to develop new ways of using Nordic health data to accelerate drug development.
Subscribe to our newsletter
Get monthly news updates and invitations to events from our oncology cluster.
RadiopharmaThor Medical opens isotope facility at Herøya
Oslo Cancer Cluster member Thor Medical has opened AlphaOne, a new facility at Herøya for producing isotopes for targeted cancer treatments.
PodcastRadium relaunches under Oslo Cancer Cluster
Oslo Cancer Cluster takes over the podcast Radium, expanding its focus on innovation, collaboration and the people driving change in the cancer field.
School collaborationFikk bli med inn i protonstrålerommet
Andre utflukt for de 19 elevene som tar Medisinsk Innovasjon som fordypning i første klasse ved Ullern videregående skole, gikk til Radiumhospitalet for å lære mer om protonbehandling. Det ble et inspirerende besøk for både elevene og omviser Jonas Asperud, som er medisinsk fysiker ved senteret.
OrganisationKlyngeleder slutter
Ketil Widerberg slutter i Oslo Cancer Cluster etter 12 år som leder av Norges eldste helseklynge.
MembersOncoinvent raises NOK 148.5m for cancer trial
New funding will help Oncoinvent advance its ovarian cancer programme and prepare for Phase III development.
EUCreating change for Europe’s cancer patients
Oslo Cancer Cluster takes a key role in a major European initiative that aims to strengthen cancer collaboration across countries and connect partners beyond the EU.
